Pharma-Bio Serv (OTCMKTS:PBSV) Stock Price Up 16.9% – Time to Buy?

Shares of Pharma-Bio Serv Inc. (OTCMKTS:PBSV) traded up 16.9% during mid-day trading on Thursday . The stock traded as high as $0.5845 and last traded at $0.5845. 4,218 shares traded hands during trading, an increase of 740% from the average session volume of 502 shares. The stock had previously closed at $0.50.

Pharma-Bio Serv Stock Performance

The firm’s 50 day moving average price is $0.50 and its 200-day moving average price is $0.54. The firm has a market capitalization of $13.39 million, a PE ratio of -58.45 and a beta of 0.61.

Pharma-Bio Serv (OTCMKTS:PBSV) last posted its earnings results on Tuesday, March 17th. The company reported $1.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $1.41. Pharma-Bio Serv had a negative net margin of 0.86% and a negative return on equity of 0.66%. The business had revenue of $2.30 million for the quarter, compared to analyst estimates of $2.70 million. On average, equities research analysts expect that Pharma-Bio Serv Inc. will post 0.09 earnings per share for the current fiscal year.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.